Ex-Amgen Exec's Startup Gets PTAB To Review Amgen Patent
A venture capital-funded startup run by a former Amgen executive has persuaded the Patent Trial and Appeal Board to investigate the validity of a cancer treatment patent owned by his former...To view the full article, register now.
Already a subscriber? Click here to view full article